查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1725100

2032 年乳糖酶市場預測：按類型、來源、形式、分銷管道、應用和地區進行的全球分析

Lactase Market Forecasts to 2032 - Global Analysis By Type (Neutral Lactase, Acid Lactase, and Other Types), Source, Form, Distribution Channel, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球乳糖酶市場規模預計在 2025 年達到 3.1374 億美元，到 2032 年將達到 5.4825 億美元，預測期內的複合年成長率為 8.3%。

乳糖酶是小腸產生的一種酶，它將牛奶和乳製品中的乳糖分解成兩種簡單的糖，即葡萄糖和半乳糖。這個過程對於身體正確消化和吸收乳糖至關重要。乳糖不耐症患者的乳糖酶產生減少，食用乳製品時會出現消化不良。乳糖酶補充劑通常用於減輕症狀。它在維持健康消化方面發揮著重要作用，尤其是在兒童早期。

根據美國國家生物技術資訊中心（NCBI）的數據，全球近65%的人口容易罹患乳糖酶缺乏症。

乳糖不耐症盛行率不斷上升

隨著患有消化器官系統問題的人尋求有效的治療方法，食品和藥物中乳糖酶的使用正在增加。人們對乳糖不耐症的認知不斷提高，促使消費者尋找乳製品替代品和消化補充劑。此外，科學研究不斷強調乳糖酶補充劑的好處，有助於推動市場採用。政府和醫療保健組織正在積極推動宣傳宣傳活動，進一步促進市場成長。因此，乳糖不耐症盛行率的上升是乳糖酶市場發展的主要驅動力。

嚴格的監管要求

為了確保乳糖酶產品的有效性和安全性，製造商必須滿足嚴格的品管要求。乳糖酶製劑的核准過程可能很長，導致產品上市延遲。此外，遵守國際貿易法規也為尋求擴大市場的公司增加了複雜性。食品和藥品安全法規的地區差異也阻礙了無縫市場滲透。

對乳製品替代品的需求不斷成長

植物來源奶和非乳製品在注重健康和乳糖不耐症的消費者中越來越受歡迎。食品製造商擴大將乳糖酶加入到他們的乳製品替代品中，以提高消化率，同時保持口感和質地。素食和彈性素食的興起進一步刺激了對無乳製品的需求。投資開發無乳糖產品的公司準備利用這個不斷擴大的細分市場。食品技術的進步不斷提高乳製品替代品的品質和可用性。

替代消化助劑的可用性

乳糖不耐症的消費者可以選擇各種益生菌和酵素補充劑來幫助消化，而無需依賴乳糖酶。此外，無乳配方不需要基於乳糖酶的解決方案，這可能會限制市場擴張。為了解決乳糖消化問題，一些消費者轉向發酵食品等自然療法。消化器官系統補充劑領域的持續技術創新可能會進一步加劇市場競爭。隨著消費者偏好的不斷變化，公司需要使其產品具有差異化，以保持相關性。

COVID-19的影響

COVID-19 疫情對乳糖酶市場產生了多方面影響，影響了生產、分銷和消費者需求。供應鏈中斷導致原料短缺，暫時影響了乳糖酶的供應。然而，疫情期間健康意識的增強促使消費者尋求消化器官系統健康解決方案，從而增加了市場興趣。疫情過後，機能性食品和膳食補充劑的需求持續成長，有利於乳糖酶產品的推廣。此外，人們對免疫支持食品配方的研究也越來越多，其中強化乳糖酶的乳製品提供了間接益處。

中性乳糖酶市場預計將在預測期內佔據最大佔有率

由於中性乳糖酶在食品和製藥行業的廣泛應用，預計將在預測期內佔據最大的市場佔有率。該部門致力於提高各種產品配方的穩定性和功能性，在不影響口感的情況下提高消化率。中性乳糖酶也廣泛應用於嬰兒營養和醫療領域。它能夠在各種 pH 條件下有效發揮作用，進一步增強了其市場吸引力。

預計在預測期內，製藥業將以最高的複合年成長率成長。

預計在預測期內，製藥業將出現最高的成長率。乳糖酶擴大被添加到藥物和膳食補充劑中，以改善消化器官系統健康。此外，醫療保健專業人員建議採用基於乳糖酶的治療方法來增強患者的消化酶平衡。酵素製劑技術的進步進一步支持了乳糖酶的藥物應用。

比最大的地區

在預測期內，亞太地區預計將佔據最大的市場佔有率，這得益於其強大的乳品加工業和不斷上升的乳糖不耐症盛行率。中國、印度和日本等國的消費者對無乳糖乳製品的興趣日益濃厚。政府推出的促進消化器官系統健康意識的法規進一步促進了該地區市場的擴張。此外，酵素製造技術的進步正在支持當地的生產和創新。大型食品和製藥公司的存在將加速市場採用和分銷策略。

複合年成長率最高的地區：

由於消費者對機能性食品和消化器官系統健康解決方案的強烈偏好，預計北美在預測期內將呈現最高的複合年成長率。無乳糖產品和營養補充劑的日益普及正在推動全部區域市場的擴張。美國和加拿大的公司正在投資研發以增強乳糖酶製劑。對基於酶的解決方案的監管支持正在促進市場成長和創新。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球乳糖酶市場類型

  • 中性乳糖酶
  • 酸性乳糖酶
  • 其他類型

6. 全球乳糖酶市場（依來源）

  • 酵母菌
  • 真菌
  • 細菌

7. 全球乳糖酶市場（依形式）

  • 乳糖酶粉
  • 液體乳糖酶

8. 全球乳糖酶市場依通路分類

  • 超級市場/大賣場
  • 網路商店
  • 專賣店
  • 其他分銷管道

9. 全球乳糖酶市場（依應用）

  • 食品/飲料
    • 牛奶
    • 起司
    • 優格
    • 冰淇淋
  • 營養補充品
  • 製藥
  • 動物飼料
  • 其他用途

第10章全球乳糖酶市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • DSM
  • Novozymes
  • Kerry Group plc
  • IFF
  • Advanced Enzyme Technologies
  • Amano Enzyme Inc.
  • Chr. Hansen Holding A/S
  • Senson
  • Merck KGaA（Sigma-Aldrich）
  • Antozyme Biotech Pvt. Ltd.
  • Infinita Biotech Private Limited
  • Aumgene Biosciences
  • Biolaxi Enzymes Pvt. Ltd.
  • Creative Enzymes
  • Nature BioScience Pvt. Ltd.
Product Code: SMRC29406

According to Stratistics MRC, the Global Lactase Market is accounted for $313.74 million in 2025 and is expected to reach $548.25 million by 2032 growing at a CAGR of 8.3% during the forecast period. Lactase is an enzyme produced in the small intestine that breaks down lactose, the sugar found in milk and dairy products, into two simpler sugars: glucose and galactose. This process is essential for proper digestion and absorption of lactose in the body. In individuals with lactose intolerance, lactase production is reduced, leading to digestive discomfort when consuming dairy. Lactase supplements are often used to help manage symptoms. It plays a vital role in maintaining healthy digestion, especially in early childhood.

According to the National Center for Biotechnology Information (NCBI), nearly 65% of the global population is prone to lactase deficiency.

Market Dynamics:

Driver:

Rising prevalence of lactose intolerance

The use of lactase enzymes in food and medication is increasing as people with digestive issues look for efficient remedies. Increased awareness regarding lactose intolerance has prompted consumers to look for dairy alternatives and digestive aids. Additionally, scientific research continues to highlight the benefits of lactase supplementation, encouraging greater market adoption. Governments and healthcare organizations are actively promoting awareness campaigns, further supporting market growth. Consequently, the rising prevalence of lactose intolerance is a major driver of the lactase market.

Restraint:

Stringent regulatory requirements

Rigorous quality control requirements must be met by manufacturers in order to guarantee the efficacy and safety of lactase-based products. The approval process for lactase formulations can be lengthy, leading to delays in product launches. Additionally, compliance with international trade regulations adds complexity for companies looking to expand their market reach. Variations in food and drug safety regulations across different regions further hinder seamless market penetration.

Opportunity:

Increasing demand for dairy alternatives

Plant-based milk and dairy-free products have gained traction among health-conscious and lactose-intolerant consumers. Food manufacturers are actively incorporating lactase enzymes to improve the digestibility of dairy alternatives while maintaining taste and texture. The rise of veganism and flexitarian diets further fuels demand for dairy-free options. Companies investing in lactose-free product development are poised to capitalize on this expanding market segment. Advancements in food technology continue to enhance the quality and accessibility of dairy alternatives.

Threat:

Availability of alternative digestion aids

Consumers with lactose intolerance can choose from various probiotics and enzyme supplements that aid digestion without relying on lactase. Additionally, dairy-free formulations eliminate the need for lactase-based solutions, potentially limiting market expansion. Some consumers prefer natural remedies such as fermented foods to manage lactose digestion issues. Continuous innovation in digestive health supplements may further increase competition within the market. Businesses must differentiate their products to maintain relevance amid evolving consumer preferences.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the lactase market, influencing production, distribution, and consumer demand. Supply chain disruptions led to shortages in raw materials, temporarily affecting lactase enzyme availability. However, heightened health awareness during the pandemic encouraged consumers to seek digestive health solutions, boosting market interest. Post-pandemic, the demand for functional foods and nutraceuticals continues to rise, benefiting lactase product adoption. Moreover, research into immune-supportive food formulations increased, indirectly benefiting lactase-enhanced dairy products.

The neutral lactase segment is expected to be the largest during the forecast period

The neutral lactase segment is expected to account for the largest market share during the forecast period, due to its widespread application across food and pharmaceutical industries. This segment offers improved stability and functionality in diverse product formulations, enhancing digestibility without compromising taste. The neutral lactase enzyme is also widely utilized in infant nutrition and medical applications. Its ability to work efficiently across various pH conditions further strengthens its market appeal.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, driven by the rising awareness of lactose-related digestive disorders. Lactase enzymes are increasingly being incorporated into medications and dietary supplements to improve digestive health. Additionally, healthcare professionals recommend lactase-based treatments to enhance digestive enzyme balance in patients. Advancements in enzyme formulation technology further boost pharmaceutical applications for lactase enzymes.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its thriving dairy industry and rising lactose intolerance prevalence. Countries such as China, India, and Japan are witnessing increased consumer interest in lactose-free dairy products. Government regulations promoting digestive health awareness further contribute to market expansion in this region. Additionally, advancements in enzyme manufacturing technology boost local production and innovation. The presence of major food and pharmaceutical companies accelerates market adoption and distribution strategies.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to its strong consumer preference for functional food and digestive health solutions. The rising adoption of lactose-free products and dietary supplements fuels market expansion across the region. Companies in the U.S. and Canada are investing in research and development to enhance lactase enzyme formulations. Regulatory support for enzyme-based solutions contributes to market growth and innovation.

Key players in the market

Some of the key players profiled in the Lactase Market include DSM, Novozymes, Kerry Group plc, IFF, Advanced Enzyme Technologies, Amano Enzyme Inc., Chr. Hansen Holding A/S, Senson, Merck KGaA (Sigma-Aldrich), Antozyme Biotech Pvt. Ltd., Infinita Biotech Private Limited, Aumgene Biosciences, Biolaxi Enzymes Pvt. Ltd., Creative Enzymes, and Nature BioScience Pvt. Ltd.

Key Developments:

In March 2025, DSM-firmenich Animal Nutrition & Health has announced a partnership with Zenkei Company Limited, a premier livestock nutrition company, to advance sustainability in Japan's feed and egg production sectors. The two organisations have signed a Memorandum of Understanding (MOU) to implement dsm-firmenich's Sustell(TM), the industry-leading life cycle assessment (LCA) platform to measure and improve the environmental footprint of animal proteins.

In March 2024, Denmark CET. University of California San Diego, among the world's top-20 research universities, and the global leader in biosolutions Novonesis are excited to launch the establishment of a leading research consortium aimed at setting a new standard for collaboration and accelerating discoveries and knowledge in Human Milk Oligosaccharides (HMOs) science.

Types Covered:

  • Neutral Lactase
  • Acid Lactase
  • Other Types

Sources Covered:

  • Yeast
  • Fungi
  • Bacteria

Forms Covered:

  • Powdered Lactase
  • Liquid Lactase

Distribution Channels Covered:

  • Supermarkets/Hypermarkets
  • Online Stores
  • Specialty Stores
  • Other Distribution Channels

Applications Covered:

  • Food & Beverages
  • Dietary Supplements
  • Pharmaceuticals
  • Animal Feed
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Lactase Market, By Type

  • 5.1 Introduction
  • 5.2 Neutral Lactase
  • 5.3 Acid Lactase
  • 5.4 Other Types

6 Global Lactase Market, By Source

  • 6.1 Introduction
  • 6.2 Yeast
  • 6.3 Fungi
  • 6.4 Bacteria

7 Global Lactase Market, By Form

  • 7.1 Introduction
  • 7.2 Powdered Lactase
  • 7.3 Liquid Lactase

8 Global Lactase Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets/Hypermarkets
  • 8.3 Online Stores
  • 8.4 Specialty Stores
  • 8.5 Other Distribution Channels

9 Global Lactase Market, By Application

  • 9.1 Introduction
  • 9.2 Food & Beverages
    • 9.2.1 Milk
    • 9.2.2 Cheese
    • 9.2.3 Yogurt
    • 9.2.4 Ice Cream
  • 9.3 Dietary Supplements
  • 9.4 Pharmaceuticals
  • 9.5 Animal Feed
  • 9.6 Other Applications

10 Global Lactase Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 DSM
  • 12.2 Novozymes
  • 12.3 Kerry Group plc
  • 12.4 IFF
  • 12.5 Advanced Enzyme Technologies
  • 12.6 Amano Enzyme Inc.
  • 12.7 Chr. Hansen Holding A/S
  • 12.8 Senson
  • 12.9 Merck KGaA (Sigma-Aldrich)
  • 12.10 Antozyme Biotech Pvt. Ltd.
  • 12.11 Infinita Biotech Private Limited
  • 12.12 Aumgene Biosciences
  • 12.13 Biolaxi Enzymes Pvt. Ltd.
  • 12.14 Creative Enzymes
  • 12.15 Nature BioScience Pvt. Ltd.

List of Tables

  • Table 1 Global Lactase Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Lactase Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Lactase Market Outlook, By Neutral Lactase (2024-2032) ($MN)
  • Table 4 Global Lactase Market Outlook, By Acid Lactase (2024-2032) ($MN)
  • Table 5 Global Lactase Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 6 Global Lactase Market Outlook, By Source (2024-2032) ($MN)
  • Table 7 Global Lactase Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 8 Global Lactase Market Outlook, By Fungi (2024-2032) ($MN)
  • Table 9 Global Lactase Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 10 Global Lactase Market Outlook, By Form (2024-2032) ($MN)
  • Table 11 Global Lactase Market Outlook, By Powdered Lactase (2024-2032) ($MN)
  • Table 12 Global Lactase Market Outlook, By Liquid Lactase (2024-2032) ($MN)
  • Table 13 Global Lactase Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 14 Global Lactase Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 15 Global Lactase Market Outlook, By Online Stores (2024-2032) ($MN)
  • Table 16 Global Lactase Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 17 Global Lactase Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 18 Global Lactase Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Lactase Market Outlook, By Food & Beverages (2024-2032) ($MN)
  • Table 20 Global Lactase Market Outlook, By Milk (2024-2032) ($MN)
  • Table 21 Global Lactase Market Outlook, By Cheese (2024-2032) ($MN)
  • Table 22 Global Lactase Market Outlook, By Yogurt (2024-2032) ($MN)
  • Table 23 Global Lactase Market Outlook, By Ice Cream (2024-2032) ($MN)
  • Table 24 Global Lactase Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 25 Global Lactase Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 26 Global Lactase Market Outlook, By Animal Feed (2024-2032) ($MN)
  • Table 27 Global Lactase Market Outlook, By Other Applications (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.